Clinical Outcomes of Anticoagulant Therapy in COVID-19 Patients with Pre-Existing Cardiovascular Diseases: A Systematic Review.

Alhawiti, Naif M; Alhawiti, Jamal M; Alshalan, Saif D; Alotaibi, Badi A; Khobrani, Ahmad Y

Alhawiti, Naif M; Alhawiti, Jamal M; Alshalan, Saif D; Alotaibi, Badi A; Khobrani, Ahmad Y.

Afiliação

Alhawiti NM; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Kingdom of Saudi Arabia.
Alhawiti JM; King Abdullah International Medical Research Center (KAIMRC), Riyadh, Kingdom of Saudi Arabia.
Alshalan SD; College of Medicine, Al Jouf University, Riyadh, Kingdom of Saudi Arabia.
Alotaibi BA; College of Medicine, Al Jouf University, Riyadh, Kingdom of Saudi Arabia.
Khobrani AY; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Kingdom of Saudi Arabia.

Infect Drug Resist ; 16: 3767-3775, 2023.

Article em En | MEDLINE | ID: mdl-37337574

Palavras-chave

COVID-19; anticoagulant; comorbidities; thrombosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Infect Drug Resist Ano de publicação: 2023 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google